Track topics on Twitter Track topics that are important to you
Cygnal Therapeutics, a spinout of Flagship Pioneering, has emerged from stealth mode to develop drugs based on pathways and targets the company has discovered in the peripheral nervous system, with an initial focus on cancer and inflammatory disease.
The post Peripheral Vision: Cygnal Looks Beyond the CNS to Develop Drugs appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: Peripheral Vision: Cygnal Looks Beyond the CNS to Develop DrugsNEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...